PHARMALLIANCE
ActiveSummary
PHARMALLIANCE has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.2m and a net result of €43,298. Equity is growing by ~15.9% per year across the filed fiscal years. Its solvency ranks better than 30% of 4231 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.9% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability37▼-8
Solvency45▲+1
Growth52=
Track record100
Bankruptcy probability, 12 months
0.9%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €55,000 at 30 days acceptable
Liquidity short (current ratio 0.47 against 0.52 in 2024; short-term debt: 53.7% and cash: 1.1% of total assets), and 80.4% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
19.6%
Return on assets
0.7%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-08-2026, 22 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
22 d late
2024
82 d late
2024
32 d late
2023
30 d late
2022
3 d late
2021
2 d late
2020
16 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 27 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, full schema
In the rankings
#4 employer in Lasne, Wholesale and retail trade sector#4 company by total assets in Lasne, Wholesale and retail trade sector#9 fastest grower in Lasne
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€43,298▼ 30.8%
2024 · €62,582
Working capital
-€1.8m▼ 24.6%
2024 · -€1.5m
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20222023202420242025
Operating result€237,167▲ 99.9%€255,927▲ 7.9%€207,750▼ 18.8%€166,076-€230,405▲ 38.7%
Net result€285,259above the sector's middle half▲ 229%€201,094above the sector's middle half▼ 29.5%€207,403above the sector's middle half▲ 3.1%€62,582within the sector's middle half-€43,298within the sector's middle half▼ 30.8%
Equity€855,307above the sector's middle half▲ 35.8%€996,401above the sector's middle half▲ 16.5%€1.1mabove the sector's middle half▲ 14.8%€1.2mabove the sector's middle half-€1.2mwithin the sector's middle half▲ 3.6%
Total assets€3.8mabove the sector's middle half▲ 4.3%€4.1mabove the sector's middle half▲ 8.9%€6.3mabove the sector's middle half▲ 53.0%€6.5mabove the sector's middle half-€6.4mabove the sector's middle half▼ 1.6%
Debt€2.9m▼ 2.4%€3.1m▲ 6.7%€5.2m▲ 65.2%€5.3m-€5.1m▼ 2.8%
Working capital-€775,696below the sector's middle half▼ 47.8%-€1.1mbelow the sector's middle half▼ 47.4%-€1.4mbelow the sector's middle half▼ 24.7%-€1.5mbelow the sector's middle half--€1.8mbelow the sector's middle half▼ 24.6%
Solvency22.6%within the sector's middle half▲ 5.2pp24.2%within the sector's middle half▲ 1.6pp18.1%within the sector's middle half▼ 6.0pp18.6%within the sector's middle half-19.6%within the sector's middle half▲ 1.0pp
Current ratio0.61below the sector's middle half▼ 0.100.51below the sector's middle half▼ 0.100.54below the sector's middle half▲ 0.030.52below the sector's middle half-0.47below the sector's middle half▼ 0.06
Return on assets (ROA)7.5%within the sector's middle half▲ 5.2pp4.9%within the sector's middle half▼ 2.7pp3.3%within the sector's middle half▼ 1.6pp1.0%within the sector's middle half-0.7%within the sector's middle half▼ 0.3pp
Staff (FTE)10.7within the sector's middle half▼ 10.8%9.6within the sector's middle half▼ 10.3%11.1within the sector's middle half▲ 15.6%12.7within the sector's middle half-13.5within the sector's middle half▲ 6.3%
above
within
below
the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
Multiple fiscal year ends fall in the same calendar year; an annual trend is not displayed.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €6.4m
Fixed assets
€4.8m ▼ 1.8%
Current assets
€1.6m ▼ 1.0%
Equity and liabilities €6.4m
Equity
€1.2m ▲ 3.6%
Debt
€5.1m ▼ 2.8%
Debt's share of the balance-sheet total falls from 81.4% to 80.4%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€426,392▲
2024 · €304,803
Cash flow
€239,285▲
2024 · €201,309
Quick ratio
0.30▼
2024 · 0.33
Debt to equity
4.11▼
2024 · 4.37
ROE
3.5%▼
2024 · 5.2%
Interest coverage
2.06▼
2024 · 3.06
Debt ≤ 1 year
€3.4m▲
2024 · €3.1m
Debt > 1 year
€1.7m▼
2024 · €2.2m
Income taxes
€33,067▲
2024 · €32,329
Staff costs
€790,856▲
2024 · €579,702
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 4,681 companies that looked in July 2024 the way this one looks now, 1.1% went bankrupt within 24 months and 97% are still going.
- Small
- 20 years or older
- solvency 10 to 30%
- a profit under 5% of the balance sheet
1.1%
went bankrupt
2.0%
stopped otherwise
97%
still going
For this company itself Checked computes a bankruptcy probability of 0.9% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 4,681 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2022 | 2023 | 2024 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | €15,000 | €6,750 | - | - | - | - |
| Remuneration, social security and pensions62 | €600,150 | €593,389 | €670,919 | €579,702 | €790,856 | ▲ 36.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €111,240 | €93,292 | €99,793 | €138,728 | €195,987 | ▲ 41.3% |
| Other operating charges640/8 | €1,380 | €1,821 | €11,106 | €1,993 | €1,845 | ▼ 7.4% |
| Non-recurring operating charges66A | - | - | €276 | €0 | €439 | - |
| Gross operating margin9900 | €949,936 | €944,428 | €989,844 | €886,497 | €1.2m | ▲ 37.6% |
| Operating profit (loss)9901 | €237,167 | €255,927 | €207,750 | €166,076 | €230,405 | ▲ 38.7% |
| Financial income75/76B | €115,709 | €37,929 | €111,958 | €28,434 | €52,695 | ▲ 85.3% |
| Recurring financial income75 | €115,709 | €37,929 | €111,958 | €28,434 | €52,695 | ▲ 85.3% |
| Financial charges65/66B | €29,798 | €34,648 | €76,989 | €99,599 | €206,735 | ▲ 108% |
| Recurring financial charges65 | €29,798 | €34,648 | €76,989 | €99,599 | €206,735 | ▲ 108% |
| Profit (loss) for the period before taxes9903 | €323,077 | €259,208 | €242,719 | €94,911 | €76,365 | ▼ 19.5% |
| Income taxes67/77 | €37,819 | €58,115 | €35,316 | €32,329 | €33,067 | ▲ 2.3% |
| Profit (loss) for the period9904 | €285,259 | €201,094 | €207,403 | €62,582 | €43,298 | ▼ 30.8% |
| Transfer to tax-exempt reserves689 | - | - | - | - | €58,940 | - |
| Profit (loss) for the period to be appropriated9905 | €285,259 | €201,094 | €207,403 | €62,582 | -€15,642 | ▼ 125% |
| Line | 2022 | 2023 | 2024 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €3.8m | €4.1m | €6.3m | €6.5m | €6.4m | ▼ 1.6% |
| Fixed assets21/28 | €2.5m | €2.9m | €4.6m | €4.9m | €4.8m | ▼ 1.8% |
| Intangible fixed assets21 | €109,500 | €73,000 | €36,500 | €127,961 | €72,174 | ▼ 43.6% |
| Tangible fixed assets22/27 | €719,675 | €1.1m | €1.7m | €1.8m | €1.8m | ▼ 1.7% |
| Land and buildings22 | €144,251 | €134,213 | €1.5m | €1.5m | €1.4m | ▼ 3.7% |
| Plant, machinery and equipment23 | €37,912 | €32,211 | €35,900 | €121,878 | €168,913 | ▲ 38.6% |
| Furniture and vehicles24 | €14,531 | €6,847 | €12,552 | €80,922 | €59,540 | ▼ 26.4% |
| Other tangible fixed assets26 | €196,951 | €164,798 | €136,583 | €123,058 | €120,224 | ▼ 2.3% |
| Assets under construction and advance payments27 | €326,031 | €790,043 | €0 | €0 | €1,800 | - |
| Financial fixed assets28 | €1.7m | €1.7m | €2.9m | €2.9m | €2.9m | = |
| Current assets29/58 | €1.2m | €1.2m | €1.7m | €1.6m | €1.6m | ▼ 1.0% |
| Stocks and contracts in progress3 | €422,158 | €454,946 | €533,815 | €577,502 | €549,879 | ▼ 4.8% |
| Stocks30/36 | €422,158 | €454,946 | €533,815 | €577,502 | €549,879 | ▼ 4.8% |
| Amounts receivable within one year40/41 | €271,026 | €290,791 | €746,429 | €616,349 | €771,370 | ▲ 25.2% |
| Trade receivables40 | €262,001 | €290,452 | €541,364 | €581,903 | €570,595 | ▼ 1.9% |
| Other amounts receivable41 | €9,026 | €339 | €205,065 | €34,446 | €200,775 | ▲ 483% |
| Current investments50/53 | €430,152 | €333,882 | €282,788 | €282,788 | €197,251 | ▼ 30.2% |
| Cash at bank and in hand54/58 | €108,835 | €113,294 | €116,107 | €127,884 | €68,305 | ▼ 46.6% |
| Deferred charges and accrued income490/1 | €6,055 | €10,027 | €4,523 | €4,102 | €5,903 | ▲ 43.9% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €3.8m | €4.1m | €6.3m | €6.5m | €6.4m | ▼ 1.6% |
| Equity10/15 | €855,307 | €996,401 | €1.1m | €1.2m | €1.2m | ▲ 3.6% |
| Contributions10/11 | €61,500 | €61,500 | €61,500 | €61,500 | €61,500 | = |
| Capital10 | €61,500 | €61,500 | €61,500 | €61,500 | €61,500 | = |
| Issued capital100 | €61,500 | €61,500 | €61,500 | €61,500 | €61,500 | = |
| Reserves13 | €24,900 | €24,900 | €24,900 | €24,900 | €83,840 | ▲ 237% |
| Non-distributable reserves130/1 | €6,150 | €6,150 | €6,150 | €6,150 | €6,150 | = |
| Legal reserve130 | €6,150 | €6,150 | €6,150 | €6,150 | €6,150 | = |
| Tax-exempt reserves132 | €18,750 | €18,750 | €18,750 | €18,750 | €77,690 | ▲ 314% |
| Profit (loss) carried forward14 | €768,907 | €910,001 | €1.1m | €1.1m | €1.1m | ▼ 1.4% |
| Amounts payable17/49 | €2.9m | €3.1m | €5.2m | €5.3m | €5.1m | ▼ 2.8% |
| Amounts payable after more than one year17 | €911,091 | €778,621 | €2.1m | €2.2m | €1.7m | ▼ 22.4% |
| Financial debts170/4 | €911,091 | €778,621 | €2.1m | €2.2m | €1.7m | ▼ 22.4% |
| Amounts payable within one year42/48 | €2.0m | €2.3m | €3.1m | €3.1m | €3.4m | ▲ 11.2% |
| Current portion of amounts payable after more than one year42 | €262,571 | €261,495 | €373,140 | €471,474 | €521,552 | ▲ 10.6% |
| Financial debts43 | €79,573 | - | - | €149,237 | €165,427 | ▲ 10.8% |
| Credit institutions430/8 | €79,573 | - | - | €149,237 | €165,427 | ▲ 10.8% |
| Trade debts44 | €1.3m | €1.5m | €1.8m | €1.9m | €1.9m | ▲ 1.1% |
| Suppliers440/4 | €1.3m | €1.5m | €1.8m | €1.9m | €1.9m | ▲ 1.1% |
| Taxes, remuneration and social security45 | €91,445 | €167,400 | €250,218 | €140,382 | €124,868 | ▼ 11.1% |
| Taxes450/3 | €28,475 | €60,005 | €133,126 | €28,153 | €4,769 | ▼ 83.1% |
| Remuneration and social security454/9 | €62,970 | €107,396 | €117,093 | €112,229 | €120,100 | ▲ 7.0% |
| Other amounts payable47/48 | €241,614 | €445,574 | €696,658 | €450,428 | €725,212 | ▲ 61.0% |
| Accrued charges and deferred income492/3 | €4,741 | €689 | €1,499 | €0 | - | - |
| Line | 2022 | 2023 | 2024 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €285,259 | €201,094 | €207,403 | €62,582 | €43,298 | ▼ 30.8% |
| + Depreciation and write-downs630 | €111,240 | €93,292 | €99,793 | €138,728 | €195,987 | ▲ 41.3% |
| Operating cash flow (approximation) | €396,499 | €294,385 | €307,197 | €201,309 | €239,285 | ▲ 18.9% |
| Investment in fixed assets (approximation) | - | -€465,230 | -€1.8m | - | -€109,107 | - |
| Change in cash | - | €4,459 | €2,813 | - | -€59,579 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
22-08
NBB filing
Annual accounts filed
fiscal year 2025 · full schema · 22 days late
2025
31-12
Financial
Weakest financial yearnet €43,298 ▼30.8%
Net result drops to €43,298, the lowest in the series.
21-10
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 82 days late
2024
02-12
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 32 days late
31-03
Financial
Equity above €1mEq €1.1m ▲14.8%
6 profitable years in a row build equity to €1.1m.
2023
30-11
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 30 days late
2022
03-11
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 3 days late
31-03
Financial
Highest result since 2019net €285,259 ▲229%
Net result €285,259, the highest in the series.
2021
02-11
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 2 days late
2020
16-11
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 16 days late
31-03
Financial
Equity above €500,000Eq €598,409 ▲32.2%
2 profitable years in a row build equity to €598,409.
2019
31-10
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2018
02-11
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 2 days late
2017
30-10
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Lasne · 4 establishment units since 2004
Ground area
5,626 m²
Building footprint
900 m²
Volume, LiDAR
16,899 m³
5 parcels, Brussels, Wallonia · tallest building 40.0 m, ±12 floors. Linked by address, not a title deed.
4
companies at this address
See who is registered here
4 establishment units
PHARMACIE DE BEAULIEU
since 20042.142.397.230
PHARMACIE COLONEL DAUMERIE
since 20062.154.771.757
Pharmacie de 4 Paves
since 20162.253.758.376
Pharmacie de Barry
since 20242.355.008.560
5 parcels
Wallonia
4
(80%)
Brussels
1
(20%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21002A0080/00H000 | Brussels | 2,235 m² | 1 · 337 m² | 40.0 m · 12 fl. |
| 25087C0409/00L000 | Wallonia | 1,223 m² | 1 · 184 m² | 8.6 m · 2 fl. |
| 51012B0399/00G002indicative | Wallonia | 1,146 m² | 1 · 197 m² | 13.1 m · 3 fl. |
| 57005A0144/00X003 | Wallonia | 639 m² | 1 · 66 m² | 9.0 m · 3 fl. |
| 53071B0236/00Z000 | Wallonia | 384 m² | 1 · 117 m² | 10.1 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
4 of 5 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
4 owners · 2 holdingsOwners 4
- Sourceaccounts LENANS 202540%
-
18%
-
18%
- 8%
Holdings 2
- DELTAPHARsubsidiary100%
- PHARMACIE de BARRYsubsidiarySourceown accounts 2024100%
According to the 2024 annual accounts of PHARMALLIANCE and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Recognitions · licences · registrations
Food safety, FASFC
2 sitesMons2.253.758.376
Oudergem2.142.397.230
Legal Entity Identifier
5299005317PXZKG6L022
Similar companies · same sector, comparable size
RAFAR
BE 0866.855.049
Chimay · Eq €1,247,150
PHILIP VAN DAMME
BE 0473.633.083
Brugge · Eq €1,244,526
PHARMACIE TASQUIN
BE 0886.144.884
Dison · Eq €1,241,369
Pharmacie FOURMY
BE 0882.900.334
Silly · Eq €1,259,188
PHARMACIE COEUR DE VILLE
BE 0472.183.528
Ottignies-Louvain-la-Neuve · Eq €1,240,148
Of 5,220 companies in sector 47730 we hold annual accounts for 3,862. 2,842 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPublic limited company
Founded28-09-2004
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Contact
Phone
068/454046Brugelette
E-mail
phciedebarry@evoluphar.beTournai
Phone
069 547718Tournai
E-invoicing
Reachable via Peppol
Peppol ID
0208:0867465852
Also
9925:BE0867465852
Registered
24-11-2023
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.